Cytokinetics (CYTK) Accounts Payables (2010 - 2026)
Cytokinetics (CYTK) posted quarterly Accounts Payables of $24.7 million for Q1 2026, up 77.23% year-over-year from $13.9 million in Q1 2025, and up 10.62% quarter-over-quarter from $22.3 million in Q4 2025.
Cytokinetics (CYTK) Accounts Payables (2010 - 2026) Analysis & Trends
Cytokinetics (CYTK) has reported Accounts Payables for 17 consecutive years, with $24.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables rose 77.23% year-over-year to $24.7 million; the TTM figure through Mar 2026 stood at $24.7 million (up 77.23% YoY), while the FY2025 annual figure was $22.3 million, up 9.66% from the prior year.
- Accounts Payables grew to $24.7 million in Q1 2026 per CYTK's latest filing, from $22.3 million in the prior quarter.
- Across five years, Accounts Payables topped out at $25.6 million in Q4 2022 and bottomed at $9.5 million in Q2 2024.
- Historically, Accounts Payables has averaged $17.2 million across 5 years, with a median of $16.2 million in 2025.
- Annual changes were most pronounced in 2022 — Accounts Payables jumped 155.42% — and 2024, when it slipped 25.29%.
- Cytokinetics' Accounts Payables stood at $25.6 million in 2022, then slipped by 16.02% to $21.5 million in 2023, then retreated by 5.29% to $20.4 million in 2024, then gained by 9.66% to $22.3 million in 2025, then gained by 10.62% to $24.7 million in 2026.
- Business Quant data shows CYTK's Accounts Payables at $24.7 million in Q1 2026, $22.3 million in Q4 2025, and $22.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Cytokinetics | 10.31 Bn | 9.14 Bn | 25.89 Mn | 20.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.51 Mn |
| Mar 31, 2026 | 24.71 Mn |
| Dec 31, 2025 | 22.34 Mn |
| Sep 30, 2025 | 22.08 Mn |
| Jun 30, 2025 | 16.23 Mn |
| Mar 31, 2025 | 13.94 Mn |
| Dec 31, 2024 | 20.37 Mn |
| Sep 30, 2024 | 11.58 Mn |
| Jun 30, 2024 | 9.47 Mn |
| Mar 31, 2024 | 12.97 Mn |
| Dec 31, 2023 | 21.51 Mn |
| Sep 30, 2023 | 13.80 Mn |
| Jun 30, 2023 | 12.56 Mn |
| Mar 31, 2023 | 17.36 Mn |
| Dec 31, 2022 | 25.61 Mn |
| Sep 30, 2022 | 14.43 Mn |
| Jun 30, 2022 | 14.08 Mn |
| Mar 31, 2022 | 19.84 Mn |
| Dec 31, 2021 | 21.09 Mn |
| Sep 30, 2021 | 16.22 Mn |